Patient P-01896
Synthetic patientNBL-101 · Day 114 · 55–64 · F · baseline S07Steering view · 3DOpen companion preview
Therapy response
Declining
Tolerance
Improving
GI state
Deteriorating
Inflammatory state
Deteriorating
Nutritional resilience
Favorable
Discontinuation risk
23%
Trajectory
Baseline → today → 30-day prediction · hover a day for signals and eventssolid = observed · dashed = predicted
- Day 0 NBL-101 started — Baseline state S07
- Day 17 Trajectory diverged from prediction — Observed response fell below the model's expected path.
What changed?
Trajectory began diverging from predicted response on Day 17.
Primary contributors, last 14 days
- Toxicity-8
- Inflammatory activity+5
- GI instability+4
- Treatment adherence+2
What helped?
No interventions yet.
LIFE OS recommendation
No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.
Daily trackers
Molecule settingsThe trackers this program marks as important, last 14 days vs the 14 before.
GI burden
Companion27.7/100
improving · -4.2 vs previous 14 d
Toxicity
Blood17.7/100
improving · -2.2 vs previous 14 d
Sleep quality
Wearable45.3/100
stable · +0.0 vs previous 14 d
Energy level
Daily log6.4/10
stable · +0.2 vs previous 14 d
Stress level
Daily log4/10
improving · -0.3 vs previous 14 d
Steps
Wearable11,205
stable · +232 vs previous 14 d
Adherence
Companion91.3 %
stable · -2.0 vs previous 14 d
This trajectory is decaying — what would help, what would not
Steering view →Heading towards failing · 73 from the failing basin, 15 from restoration.
Would help
- No untried action with strong evidence. Compose one from primitives.
- More fatGI -3.1 next day on high-intake days · n 17
Would not help
- HY-01 Hydration Protocolonly 38% improved among 8 similar
- Keep histamine lowGI +5 next day on high-intake days · n 24
State influencers · digestive
Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.
- Histamine load+5detractor · 95%
- Dietary fat load-3.1supporter · 68%
- Simple carbohydrates-1.6no signal · 29%
- Spicy / capsaicin-1.5no signal · 23%
- Alcohol-0.9no signal · 18%
- Insoluble fibre+0.1no signal · 15%
Biological layers
Which pathways look influenced, and by which layer of this person's biology.
Pathways under pressure
- Inflammatory signalling ↑35
- MicrobiomeBacteroides fragilis expansion
- WearableHRV 38 ms, trending down
- Mucosal barrier integrity ↓30
- DNAFUT2 non-secretor lowers mucosal fucosylation
- Butyrate / short-chain fatty acid production ↓25
- MicrobiomeF. prausnitzii depleted
- Autonomic recovery ↓25
- WearableResting HR 74 bpm
DNA
Fictional pharmacogenomic panel
- FUT2 rs601338 AA (non-secretor)Reduced mucosal fucosylation
- CYP2D6 Rapid metabolizerExpected exposure
- MTHFR C677TReduced folate turnover
Microbiome
Shannon diversity 4.5 · butyrate capacity 81/100
- Akkermansia muciniphilaNormal
- Faecalibacterium prausnitziiLow
- Bacteroides fragilisHigh
- Bifidobacterium longumLow
- EnterobacteriaceaeHigh
Wearable, last 14 days
daily evolution fed into the runtime
- HRV
- 38 ms
- Sleep
- 7.6 h
- Steps
- 9,832
- Resting HR
- 73 bpm
Daily log: GI score 28, nutritional resilience 61, adherence 91.
What this patient sees in NostraAI
The content that steers the trajectory: what to eat, what to do, what to take.
What to eat
- Keep meals regular; three to four moderate portions spaced through the day
- Include a cooked vegetable portion with each main meal
- Add one soluble-fibre source (oats, cooked carrots, banana) to breakfast
- Avoid known triggers for now: fried or oily food, dairy, alcohol
What to do
- Log the daily check-in; one line is enough
- Keep the current walking rhythm
- Keep the sleep window steady
- Keep hydration steady: small amounts through the day rather than large volumes at once
What to take
- Take the scheduled dose as agreed with your care team
- No additional supplements this week
- Fictional demo item: continue vitamin D as before
284 biologically similar trajectories
Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.
| Patient | Similarity | Baseline | Intervention | Outcome | Response today |
|---|---|---|---|---|---|
| P-01503 | 45% | S15 | ME-01 | improved | 80 |
| P-01798 | 41% | S08 | NP-02 | improved | 78 |
| P-01329 | 37% | S08 | BR-03 | improved | 79 |
| P-01495 | 36% | S07 | BR-03 | improved | 85 |
| P-01479 | 35% | S15 | DT-01 | improved | 84 |
| P-01654 | 35% | S08 | CR-01 | improved | 85 |
| P-01804 | 35% | S19 | AD-05 | improved | 61 |
| P-01625 | 34% | S06 | SC-12 | improved | 83 |
| P-01796 | 34% | S09 | SC-12 | improved | 86 |
| P-01855 | 34% | S04 | DT-01 | improved | 73 |
| P-01571 | 33% | S13 | SC-12 | improved | 57 |
| P-01439 | 32% | S18 | ME-01 | improved | 79 |